Astarte Medical, a clinical intelligence company, using software and predictive analytics to improve infant care, secured $7.6 million in Series A-1 financing. Investors in the
![Astarte Medical Raises $7.6 Million to Advance its Preterm Infant Technology](https://mercomcapital.com/wp-content/uploads/2021/09/Astarte-Medical-Raises-7.6-Million-to-Advance-its-Preterm-Infant-Technology.png)
Astarte Medical, a clinical intelligence company, using software and predictive analytics to improve infant care, secured $7.6 million in Series A-1 financing. Investors in the
Vivante Health, a provider of digital medicine for gut health and disease, closed its $5.8 million Series A1 funding round. Lifeforce Capital and European investment